Objective: Hydrogen sulfide (H2S), as a novel gasotransmitter, plays important roles in a number of physiological and pathological processes. Its effectiveness has been demonstrated in different types of brain disorders but not in repetitive febrile seizure (febrile status epilepticus; FSE) models. This study aims to test whether a donor of H2S sodium sulfhydrate (NaHS) is also effective for FSE in rats. Methods: FSE was induced in rat pups on postnatal day 10 in water at 45.0 ± 0.1°C for 10 consecutive days with or without preadministration of NaHS. Following evaluation of the latency and duration of hyperthermic seizures, impairment in learning and memory was measured by the Morris water maze test. Moreover, alterations of the microglial response and the production of proinflammatory cytokines IL-1β and TNF-α were calculated in the hippocampus. Results: We found that NaHS significantly increased the latency and decreased the duration of hyperthermic seizures. Furthermore, NaHS-treated pups showed less impairment in learning and memory. In addition, NaHS inhibited FSE-induced microglial responses and suppressed the production of IL-1β and TNF-α in the hippocampus. Conclusion: NaHS appears to be effective for the treatment of FSE in infants and children, in part due to its anti-inflammatory action.

Keywords:
Febrile status epilepticus, Learning and memory, Microglia, Neuroinflammation, Hydrogen sulfide
1.
Hauser WA: The prevalence and incidence of convulsive disorders in children. Epilepsia 1994;35(suppl 2):S1-S6.
2.
Scott RC: Consequences of febrile seizures in childhood. Curr Opin Pediatr 2014;26:662-667.
3.
Yoong M, Martinos MM, Chin RF, Clark CA, Scott RC: Hippocampal volume loss following childhood convulsive status epilepticus is not limited to prolonged febrile seizures. Epilepsia 2013;54:2108-2115.
4.
Scott RC, King MD, Gadian DG, Neville BG, Connelly A: Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study. Brain 2003;126:2551-2557.
5.
Frank LM, Shinnar S, Hesdorffer DC, Shinnar RC, Pellock JM, Gallentine W, Nordli DR Jr, Epstein LG, Moshe SL, Lewis DV, Sun S, Team FS: Cerebrospinal fluid findings in children with fever-associated status epilepticus: results of the consequences of prolonged febrile seizures (FEBSTAT) study. J Pediatr 2012;161:1169-1171.
6.
Herrera EA, Alvarez SY, Cobox O, Villeda T: Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology 2009;72:1533; author reply 1533-1534.
7.
Yagoubi N, Jomni Y, Sakly M: Hyperthermia-induced febrile seizures have moderate and transient effects on spatial learning in immature rats. Behav Neurol 2015;2015:924303.
8.
Nagpure BV, Bian JS: Brain, learning, and memory: role of H2S in neurodegenerative diseases. Handb Exp Pharmacol 2015;230:193-215.
9.
Kimura Y, Kimura H: Hydrogen sulfide protects neurons from oxidative stress. FASEB J 2004;18:1165-1167.
10.
Wallace JL, Wang R: Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat Rev Drug Discov 2015;14:329-345.
11.
Paul BD, Snyder SH: H2s: A novel gasotransmitter that signals by sulfhydration. Trends Biochem Sci 2015;40:687-700.
12.
Eto K, Ogasawara M, Umemura K, Nagai Y, Kimura H: Hydrogen sulfide is produced in response to neuronal excitation. J Neurosci 2002;22:3386-3391.
13.
Hu LF, Wong PT, Moore PK, Bian JS: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 2007;100:1121-1128.
14.
Yin WL, He JQ, Hu B, Jiang ZS, Tang XQ: Hydrogen sulfide inhibits MPP(+)-induced apoptosis in PC12 cells. Life Sci 2009;85:269-275.
15.
Palmer GC, Borrelli AR, Hudzik TJ, Sparber S: Acute heat stress model of seizures in weanling rats: influence of prototypic anti-seizure compounds. Epilepsy Res 1998;30:203-217.
16.
Fan Y, Liu M, Wu X, Wang F, Ding J, Chen J, Hu G: Aquaporin-4 promotes memory consolidation in Morris water maze. Brain Struct Funct 2013;218:39-50.
17.
Jensen FE, Baram TZ: Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility. Ment Retard Dev Disabil Res Rev 2000;6:253-257.
18.
Baram TZ, Gerth A, Schultz L: Febrile seizures: an appropriate-aged model suitable for long-term studies. Brain Res Dev Brain Res 1997;98:265-270.
19.
Martinos MM, Yoong M, Patil S, Chin RF, Neville BG, Scott RC, de Haan M: Recognition memory is impaired in children after prolonged febrile seizures. Brain 2012;135:3153-3164.
20.
Xiong Y, Zhou H, Zhang L: Influences of hyperthermia-induced seizures on learning, memory and phosphorylative state of camkiialpha in rat hippocampus. Brain Res 2014;1557:190-200.
21.
Toth Z, Yan XX, Haftoglou S, Ribak CE, Baram TZ: Seizure-induced neuronal injury: vulnerability to febrile seizures in an immature rat model. J Neurosci 1998;18:4285-4294.
22.
Dube C, Yu H, Nalcioglu O, Baram TZ: Serial MRI after experimental febrile seizures: altered T2 signal without neuronal death. Ann Neurol 2004;56:709-714.
23.
Dube C, Richichi C, Bender RA, Chung G, Litt B, Baram TZ: Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. Brain 2006;129:911-922.
24.
Dube CM, Brewster AL, Richichi C, Zha Q, Baram TZ: Fever, febrile seizures and epilepsy. Trends Neurosci 2007;30:490-496.
25.
Kimura H: Physiological role of hydrogen sulfide and polysulfide in the central nervous system. Neurochem Int 2013;63:492-497.
26.
Kamat PK, Kalani A, Tyagi N: Role of hydrogen sulfide in brain synaptic remodeling. Methods Enzymol 2015;555:207-229.
27.
Feng X, Zhou YL, Meng X, Qi FH, Chen W, Jiang X, Xu GY: Hydrogen sulfide increases excitability through suppression of sustained potassium channel currents of rat trigeminal ganglion neurons. Mol Pain 2013;9:4.
28.
Luo Y, Wu PF, Zhou J, Xiao W, He JG, Guan XL, Zhang JT, Hu ZL, Wang F, Chen JG: Aggravation of seizure-like events by hydrogen sulfide: involvement of multiple targets that control neuronal excitability. CNS Neurosci Ther 2014;20:411-419.
29.
Han Y, Qin J, Chang X, Yang Z, Tang X, Du J: Hydrogen sulfide may improve the hippocampal damage induced by recurrent febrile seizures in rats. Biochem Biophys Res Commun 2005;327:431-436.
30.
Choi J, Nordli DR Jr, Alden TD, DiPatri A Jr, Laux L, Kelley K, Rosenow J, Schuele SU, Rajaram V, Koh S: Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 2009;6:38.
31.
Marchi N, Granata T, Janigro D: Inflammatory pathways of seizure disorders. Trends Neurosci 2014;37:55-65.
32.
Choi J, Min HJ, Shin JS: Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J Neuroinflammation 2011;8:135.
33.
Avignone E, Ulmann L, Levavasseur F, Rassendren F, Audinat E: Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J Neurosci 2008;28:9133-9144.
34.
Lu Y, Gao L, Li L, Zhu Y, Wang Z, Shen H, Song K: Hydrogen sulfide alleviates peritoneal fibrosis via attenuating inflammation and TGF-beta1 synthesis. Nephron 2015;131:210-219.
35.
Li F, Zhang P, Zhang M, Liang L, Sun X, Li M, Tang Y, Bao A, Gong J, Zhang J, Adcock I, Chung KF, Zhou X: Hydrogen sulfide prevents and partially reverses ozone-induced features of lung inflammation and emphysema in mice. Am J Respir Cell Mol Biol 2016;55:72-81.
36.
Liu W, Xu C, You X, Olson DM, Chemtob S, Gao L, Ni X: Hydrogen sulfide delays LPS- induced preterm birth in mice via anti-inflammatory pathways. PLoS One 2016;11:e0152838.
37.
Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006;20:2118-2120.
38.
Sulen A, Gullaksen SE, Bader L, McClymont DW, Skavland J, Gavasso S, Gjertsen BT: Signaling effects of sodium hydrosulfide in healthy donor peripheral blood mononuclear cells. Pharmacol Res 2016, DOI: 10.1016/j.phrs.2016.08.018.
39.
Xuan A, Long D, Li J, Ji W, Zhang M, Hong L, Liu J: Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer's disease. J Neuroinflamm 2012;9:202.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.